Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-Effective?
Cardiovascular Drugs and Therapy - Netherlands
doi 10.1007/s10557-017-6720-7
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Springer Science and Business Media LLC